Madrigal Pharmaceuticals Inc (MDGL)
R&D Expenses
$91.18M
Quarterly · Period ending: · USD
MDGL R&D Expenses
Latest reported$91.18Mperiod ending
Latest reported$91.18Mperiod ending
MDGL Quarterly R&D Expenses ($5.63M → $91.18M)
Quarterly R&D Expenses
High-resolution chart · PNG
MDGL r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 91,178,000 | |
| 108,692,000 | |
| 116,268,000 | |
| 174,004,000 | |
| 54,081,000 | |
| 44,172,000 | |
| 25,648,000 | |
| 68,742,000 | |
| 71,091,000 | |
| 71,237,000 | |
| 70,640,000 | |
| 70,951,000 | |
| 68,605,000 | |
| 62,154,000 | |
| 70,742,000 | |
| 68,271,000 | |
| 58,499,000 | |
| 47,929,000 | |
| 52,889,000 | |
| 54,873,000 | |
| 51,632,000 | |
| 45,770,000 | |
| 53,429,000 | |
| 53,292,000 | |
| 44,688,000 | |
| 33,400,000 | |
| 24,910,000 | |
| 19,447,000 | |
| 15,594,000 | |
| 12,373,000 | |
| 8,871,000 | |
| 6,211,000 | |
| 5,109,000 | |
| 5,198,000 | |
| 6,512,000 | |
| 6,682,000 | |
| 6,816,000 | |
| 4,380,000 | |
| 5,524,000 | |
| 7,805,000 | |
| -103,000 | |
| 3,407,000 | |
| 7,246,000 | |
| 14,413,000 | |
| 16,377,000 | |
| 16,182,000 | |
| 15,653,000 | |
| 16,208,000 | |
| 18,761,000 | |
| 17,583,000 | |
| 19,981,000 | |
| 17,623,000 | |
| 17,876,000 | |
| 16,380,000 | |
| 14,351,000 | |
| 11,743,000 | |
| 11,252,000 | |
| 12,066,000 | |
| 10,859,000 | |
| 10,751,000 | |
| 10,417,000 | |
| 9,436,000 | |
| 9,346,000 | |
| 11,023,000 | |
| 9,688,000 | |
| 10,195,000 | |
| 9,233,000 | |
| 9,084,000 | |
| 10,098,000 | |
| 22,639,000 | |
| 23,031,000 | |
| 24,058,000 | |
| 18,342,000 | |
| 16,150,000 | |
| 13,334,000 | |
| 11,542,000 | |
| 13,613,000 | |
| 14,398,000 | |
| 10,528,000 | |
| 13,325,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 16,218,000 | |
| 5,625,000 |